Verastem, Inc.
(NASDAQ : VSTM)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. 2.30%353.600.0%$6728.26m
BNTXBioNTech SE 5.04%328.350.0%$1093.01m
SNSSSunesis Pharmaceuticals, Inc. -2.32%10.520.7%$735.39m
NVAXNovavax, Inc. -2.54%179.3379.8%$649.04m
AMGNAmgen, Inc. -0.38%241.541.3%$499.24m
BIIBBiogen, Inc. -0.74%326.731.7%$431.26m
VRTXVertex Pharmaceuticals, Inc. 0.60%201.581.9%$414.73m
GILDGilead Sciences, Inc. -2.21%68.291.0%$401.30m
REGNRegeneron Pharmaceuticals, Inc. -1.46%574.612.7%$353.89m
ILMNIllumina, Inc. 0.84%495.753.5%$264.01m
NTLAIntellia Therapeutics, Inc. 3.53%141.852.3%$263.90m
CRSPCRISPR Therapeutics AG 1.70%121.020.6%$144.72m
EXASEXACT Sciences Corp. -3.64%107.8418.1%$123.59m
SGENSeagen Inc. 4.38%153.395.8%$120.23m
CYTKCytokinetics, Inc. 1.09%29.683.2%$115.29m

Company Profile

Verastem, Inc. is a biopharmaceutical company, which engages in the development and commercialization of drugs for the treatment of cancer. The company was founded by Richard H. Aldrich, Michelle Dipp, Piyush Gupta, Satish Jindal, Eric S. Lander, Robert F. Weinberg, and Christoph H. Westphal on August 4, 2010 and is headquartered in Needham, MA.